These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2906191)

  • 41. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
    Schallreuter KU; Pittelkow MR
    Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo study of skin mechanical properties in psoriasis vulgaris.
    Dobrev H
    Acta Derm Venereol; 2000; 80(4):263-6. PubMed ID: 11028858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Urea in combination with dithranol in treating psoriasis vulgaris].
    Przybilla B; Kaudewitz P; Bieber K
    Hautarzt; 1989; 40 Suppl 9():54-7. PubMed ID: 2681078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions.
    Hagforsen E; Lampinen M; Paivandy A; Weström S; Velin H; Öberg S; Pejler G; Rollman O
    Br J Dermatol; 2017 Jul; 177(1):179-187. PubMed ID: 28117878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
    Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
    Christensen OB; Holst R; Hradil E; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():96-100; discussion 101. PubMed ID: 2609898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does UV-A potentiate 'short contact' dithranol therapy?
    Reshad H; Barth JH; Darley CR; Baker H
    Br J Dermatol; 1984 Aug; 111(2):155-8. PubMed ID: 6466557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis.
    Monastirli A; Georgiou S; Pasmatzi E; Sakkis T; Badavanis G; Drainas D; Sagriotis A; Tsambaos D
    Skin Pharmacol Appl Skin Physiol; 2002; 15(4):246-51. PubMed ID: 12218286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calmodulin inhibition by anthralin? Investigations in vitro and in vivo.
    Wollina U; Klinger R; Wetzker R; Knopf B
    Dermatologica; 1989; 179(2):61-3. PubMed ID: 2529149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
    Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
    Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of short-contact therapy with dithranol in childhood psoriasis.
    Zvulunov A; Anisfeld A; Metzker A
    Int J Dermatol; 1994 Nov; 33(11):808-10. PubMed ID: 7822090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes.
    Bruch-Gerharz D; Fehsel K; Suschek C; Michel G; Ruzicka T; Kolb-Bachofen V
    J Exp Med; 1996 Nov; 184(5):2007-12. PubMed ID: 8920887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involved and Uninvolved Psoriatic Keratinocytes Display a Resistance to Apoptosis that may Contribute to Epidermal Thickness.
    Eding CB; Enerbäck C
    Acta Derm Venereol; 2017 Jul; 97(7):788-796. PubMed ID: 28350039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol.
    Hutchinson PE; Marks R; White J
    Dermatology; 2000; 201(2):139-45. PubMed ID: 11053917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
    Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dithranol allergy: fact or fiction?
    Burden AD; Stapleton M; Beck MH
    Contact Dermatitis; 1992 Nov; 27(5):291-3. PubMed ID: 1493682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Modified dithranol minute therapy of psoriasis vulgaris].
    Chlebarov S; Rauh M
    Z Hautkr; 1988 Aug; 63(8):658-62. PubMed ID: 3188606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrastructural changes of mitochondria in dithranol-treated psoriatic epidermis.
    Swanbeck G; Lundquist PG
    Acta Derm Venereol; 1972; 52(2):94-8. PubMed ID: 4126316
    [No Abstract]   [Full Text] [Related]  

  • 60. Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis.
    Grattan CE; Christopher AP; Robinson M; Cowan MA
    Br J Dermatol; 1988 Nov; 119(5):623-6. PubMed ID: 3061441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.